Adamis pharmaceuticals schedules fourth quarter and full year 2020 financial results conference call and business update

San diego, april 13, 2021 (globe newswire) -- adamis pharmaceuticals corporation (nasdaq: admp), a biopharmaceutical company developing and commercializing specialty products for respiratory disease, allergy and opioid overdose, today announced that it will host an investor conference call on thursday, april 15, 2021 at 2 p.m. pacific time to discuss its financial and operating results for the fourth quarter and full year 2020 as well as provide a business update. the company's press release concerning its fourth quarter 2020 financial results will be available after 1 p.m. pacific time on april 15, 2021, on its website at www.adamispharmaceuticals.com, and the company also expects to file its annual report on form 10-k for year ended december 31, 2020 on that date.
ADMP Ratings Summary
ADMP Quant Ranking